Unknown

Dataset Information

0

Synthesis of hyaluronate in differentiated teratocarcinoma cells. Mechanism of chain growth.


ABSTRACT: Hyaluronate could be labelled in vivo with [32P]phosphate. [32P]UDP in an alpha-glycosidic linkage constituted the reducing end of membrane-bound hyaluronate. The UDP is liberated during further chain elongation, indicating that chain growth occurs at the reducing end. [3H]Uridine could be incorporated into hyaluronate during synthesis on the isolated membraneous fraction from [3H]UDP-GlcNAc and [3H]UDP-GlcA, confirming the identification of UDP as a constituent of membrane-bound hyaluronate. These results led to a model of hyaluronate chain elongation at the reducing end by alternate addition of the chains to the substrates. Membrane-bound pyrophosphatases or 5'-nucleotidase are suggested as modulators of hyaluronate synthesis.

SUBMITTER: Prehm P 

PROVIDER: S-EPMC1154343 | biostudies-other | 1983 Apr

REPOSITORIES: biostudies-other

Similar Datasets

| S-EPMC1154342 | biostudies-other
| S-EPMC3864836 | biostudies-literature
| S-EPMC8603211 | biostudies-literature
| S-EPMC1702558 | biostudies-literature
| S-EPMC1144646 | biostudies-other
| S-EPMC3407877 | biostudies-literature
| S-EPMC6071666 | biostudies-literature
2015-04-08 | GSE56616 | GEO
| S-EPMC7970265 | biostudies-literature
| S-EPMC5481553 | biostudies-literature